World Asset Management’s Ionis Pharmaceuticals IONS Stock Holding History

World Asset Management’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-3,697	Closed	-$223K	–	997
2019 Q4	$223K	Sell	3,697 -572	-13%	-$34.1K	0.01%	934
2019 Q3	$256K	Sell	4,269 -17	-0.4%	-$1.11K	0.01%	904
2019 Q2	$275K	Buy	4,286 +39	+0.9%	+$2.76K	0.01%	891
2019 Q1	$345K	Sell	4,247 -124	-3%	-$8K	0.02%	787
2018 Q4	$236K	Sell	4,371 -236	-5%	-$12K	0.01%	869
2018 Q3	$238K	Buy	+4,607	New	+$216K	0.01%	1065
2018 Q1	–	Sell	-5,618	Closed	-$283K	–	1405
2017 Q4	$283K	Sell	5,618 -73	-1%	-$4K	0.01%	1166
2017 Q3	$289K	Buy	5,691 +77	+1%	+$4.03K	0.01%	1152
2017 Q2	$286K	Buy	5,614 +187	+3%	+$8.71K	0.01%	1129
2017 Q1	$218K	Buy	5,427 +1,163	+27%	+$52.2K	0.01%	1244
2016 Q4	$204K	Buy	+4,264	New	+$169K	0.01%	1244
2015 Q2	–	Sell	-3,443	Closed	-$219K	–	1218
2015 Q1	$219K	Sell	3,443 -107	-3%	-$7.26K	0.01%	1234
2014 Q4	$219K	Buy	+3,550	New	+$175K	0.01%	1232
2014 Q2	–	Sell	-5,682	Closed	-$246K	–	1540
2014 Q1	$246K	Sell	5,682 -28	-0.5%	-$1.36K	0.01%	1276
2013 Q4	$227K	Sell	5,710 -2,933	-34%	-$104K	0.01%	1339
2013 Q3	$324K	Sell	8,643 -1,722	-17%	-$51.4K	0.01%	1233
2013 Q2	$279K	Buy	+10,365	New	+$220K	0.01%	1367

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

World Asset Management's IONS Position: Q1 2020 in Review

World Asset Management sold out of Ionis Pharmaceuticals (IONS) in Q1 2020, closing a stake of 3,697 shares — an estimated $223K sold.

World Asset Management first reported a position in IONS in Q2 2013 and held it in 17 quarters. The position peaked at $345K in Q1 2019. 362 funds tracked by Wall St. Rank hold IONS as of Q1 2020.

World Asset Management reported no remaining Ionis Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
World Asset Management sold 3,697 Ionis Pharmaceuticals shares in Q1 2020, an estimated $223K.
World Asset Management first reported a position in Ionis Pharmaceuticals in Q2 2013 and held it in 17 quarters.
World Asset Management's Ionis Pharmaceuticals position peaked at $345K in Q1 2019.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2020.

Based on World Asset Management's 13F filing for Q1 2020, filed 23 Apr 2020.